Wearable cardioverter defibrillator after cardiac surgery: Analysis of real-life data from patients at transient risk of sudden cardiac death
- PMID: 36723848
- PMCID: PMC10023876
- DOI: 10.1111/anec.13048
Wearable cardioverter defibrillator after cardiac surgery: Analysis of real-life data from patients at transient risk of sudden cardiac death
Abstract
Background: Especially in the first 3 months after cardiac surgery, patients are at transient risk of sudden cardiac death (SCD). To close the gap between hospital discharge and the final implantable cardioverter-defibrillator (ICD) decision, guidelines recommend temporarily using a wearable cardioverter-defibrillator (WCD) to protect these patients from SCD. We investigated real-life data on the safety, effectiveness, and compliance of the WCD in this population.
Methods: Data for analysis were collected via the Zoll Patient Management Network (ZPM) from patients who underwent cardiac surgery and who were discharged with a WCD between 2018 and 2021 at the Cardiac Surgery Center of the University of Erlangen in Germany.
Results: The majority of the 55 patients were male (90.9%) and underwent a coronary artery bypass graft (80.0%). The number of patients with left ventricular ejection fraction (LVEF) >35% increased from 9.1% at the beginning of WCD use to 58.2% at the end of WCD use. Six ventricular tachycardia (VT) episodes occurred in four patients. The WCD appropriately defibrillated two patients with VT episodes. There were no inadequate shocks and no fatalities during the observation time. WCD wearing compliance was high, with a median wear time of 23.3 h/day.
Conclusion: This retrospective analysis in a single cardiac surgery center confirms prior data on the safety and effectiveness of the WCD in patients in post-surgery care in a real-life setting. The WCD successfully protected patients from SCD during life-threatening VT episodes. WCD wearing compliance was high.
Keywords: heart failure; sudden cardiac death; ventricular tachycardia; wearable cardioverter defibrillator.
© 2023 The Authors. Annals of Noninvasive Electrocardiology published by Wiley Periodicals LLC.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
References
-
- ACC/AHA/HRS , Buxton, A. E. , Chalkins, H. , Callans, D. J. , DiMarco, J. P. , Fisher, J. D. , Greene, H. L. , Haines, D. E. , Hayes, D. L. , Heidenreich, P. A. , Miller, J. M. , Poppas, A. , Prystowsky, E. N. , Schoenfeld, M. H. , Zimetbaum, P. J. , Goff, D. C. , Grover, F. L. , Malenka, D. J. , Peterson, E. D. , … Redberg, R. F. (2006). ACC/AHA/HRS 2006 key data elements and definitions for electrophysiological studies and procedures: A report of the American College of Cardiology/American Heart Association task force on clinical data standards. Circulation, 114(23), 2534–2570. - PubMed
-
- Bayés de Luna, A. , Coumel, P. , & Leclercq, J. F. (1989). Ambulatory sudden cardiac death: Mechanisms of production of fatal arrhythmia on the basis of data from 157 cases. American Heart Journal, 117(1), 151–159. - PubMed
-
- Demirovic, J. , & Myerburg, R. J. (1994). Epidemiology of sudden coronary death: An overview. Progress in Cardiovascular Diseases, 37(1), 39–48. - PubMed
-
- Deneke, T. , Bosch, R. , Eckardt, L. , Nowak, B. , Schwab, J. O. , Sommer, P. , Veltmann, C. , & Helms, T. M. (2019). Wearable cardioverter defibrillator (WCD)—Indications and use. Recommendations of the working group 1 of the German cardiac society (DGK). Der Kardiologe, 13, 292–304.
-
- Kaul, T. K. , Fields, B. L. , Riggins, L. S. , Wyatt, D. A. , & Jones, C. R. (1998). Venticular arrhythmia following successful myocardial revascularization: Incidence, predictors, and prevention. European Journal of Cardio‐Thoracic Surgery, 13(6), 629–636. - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources